08:00 , Nov 10, 2003 |  BC Week In Review  |  Company News

Akceli, Dharmacon deal

The companies will combine their technologies for potential use in gene-silencing studies. Dharmacon will supply siRNA reagents, and Akceli will provide reverse transfection materials and carry out experiments. The partners will assess the efficacy of...
08:00 , Dec 23, 2002 |  BioCentury  |  Finance

Atlas Venture VI

Atlas Venture VI Company Country Business Raised to date Akceli U.S. Microarrays $6.5 Alnylam U.S. RNA interference $17.0 Aureon U.S. Molecular pathology $15.0 Axovan ...
07:00 , Aug 5, 2002 |  BC Week In Review  |  Company News

Akceli scientific advisory board update

Akceli Inc., Cambridge, Mass.   Business: Microarrays, Functional genomics   Appointed: David Bartel, associate professor of biology at the Massachusetts Institute of Technology; Joan Brugge, professor of cell biology at Harvard Medical School; Michael Greenberg, professor of...
07:00 , Aug 5, 2002 |  BC Week In Review  |  Company News

Akceli management update

Akceli Inc., Cambridge, Mass.   Business: Microarrays   Hired: Brent Kreider as SVP of technology, formerly VP of biological research at Phylos Inc.   ...